Amerise Biosciences Ltd Stock Price Today (NSE: AMERISE)
Fundamental Score
Amerise Biosciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amerise Biosciences Ltd share price today is ₹0.85, up +0.00% on NSE/BSE as of 22 September 2026. Amerise Biosciences Ltd (AMERISE) is a Small-cap company in the Plastic Products - Industrial sector with a market capitalisation of ₹6.28 (Cr). The 52-week high for AMERISE share price is ₹1.03 and the 52-week low is ₹0.50. At a P/E ratio of 313.91x, AMERISE is currently trading above its industry average P/E of 20.83x. The company has a Return on Equity (ROE) of 0.37% and a debt-to-equity ratio of 0.00.
Amerise Biosciences Ltd Share Price Chart — NSE/BSE Historical Performance
Amerise Biosciences Ltd share price chart: -7.69% return over the past month. 52-week high ₹1.03, 52-week low ₹0.50.
Amerise Biosciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹0.81 | ₹0.84 | ₹0.80 | ₹0.84 | 75.74K (Cr) | |
| ₹0.82 | ₹0.82 | ₹0.80 | ₹0.80 | 1.86L (Cr) | |
| ₹0.84 | ₹0.84 | ₹0.83 | ₹0.83 | 25.92K (Cr) | |
| ₹0.83 | ₹0.84 | ₹0.83 | ₹0.84 | 17.88K (Cr) | |
| ₹0.84 | ₹0.84 | ₹0.83 | ₹0.83 | 22.70K (Cr) | |
| ₹0.85 | ₹0.85 | ₹0.85 | ₹0.85 | 1.87L (Cr) | |
| ₹0.85 | ₹0.85 | ₹0.85 | ₹0.85 | 24.80K (Cr) | |
| ₹0.85 | ₹0.85 | ₹0.85 | ₹0.85 | 18.97K (Cr) | |
| ₹0.82 | ₹0.85 | ₹0.82 | ₹0.85 | 1.69L (Cr) | |
| ₹0.85 | ₹0.85 | ₹0.82 | ₹0.82 | 1.04L (Cr) |
Amerise Biosciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1.01 | ₹1.03 | ₹0.80 | ₹0.84 | -16.83% | |
| ₹0.82 | ₹1.02 | ₹0.77 | ₹1.01 | +23.17% | |
| ₹0.71 | ₹0.94 | ₹0.64 | ₹0.82 | +15.49% | |
| ₹0.70 | ₹0.80 | ₹0.68 | ₹0.71 | +1.43% | |
| ₹0.59 | ₹0.78 | ₹0.59 | ₹0.69 | +16.95% | |
| ₹0.69 | ₹0.72 | ₹0.50 | ₹0.59 | -14.49% | |
| ₹0.61 | ₹0.84 | ₹0.60 | ₹0.70 | +14.75% | |
| ₹0.61 | ₹0.70 | ₹0.53 | ₹0.61 | +0.00% | |
| ₹0.62 | ₹0.70 | ₹0.51 | ₹0.61 | -1.61% | |
| ₹0.63 | ₹0.73 | ₹0.55 | ₹0.62 | -1.59% | |
| ₹0.65 | ₹0.71 | ₹0.55 | ₹0.63 | -3.08% | |
| ₹0.70 | ₹0.71 | ₹0.65 | ₹0.65 | -7.14% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amerise Biosciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amerise Biosciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMERISE across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Excellent EPS Growth (15.54% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (15.54% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (0.37%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.37%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (3.08%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 313.91x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-45.45%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-57.89%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Liquidity Concerns (Current Ratio: 0.01)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amerise Biosciences Ltd vs Plastic Products - Industrial Peers
Peer Comparison - Plastic Products - Industrial
Compare Amerise Biosciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amerise Biosciences LtdAmerise Bioscie...Selected✓ AMERISE • 531681 | 8.8/100 | ₹0.85₹1 | ₹6.28₹6.28 | 313.91Average 313.9 Average | 0.37%Poor 0.37% Poor | 0.37%Poor 0.37% Poor | 0.00Excellent 0.0 Excellent | 15.54%Excellent 15.54% Excellent | — — | 0.00% |
Supreme Industries LimitedSupreme Industr... SUPREMEIND • 509930 | 56.2/100 | ₹3510.00₹3510 | ₹44594.55₹44594.55 | 43.19Average 43.2 Average | 0.00%Poor 0.00% Poor | 19.13%Good 19.13% Good | 0.00Excellent 0.0 Excellent | -0.89%Poor -0.89% Poor | 12.03%Good 12.03% Good | 1.04% |
Astral LimitedAstral Limited... ASTRAL • 532830 | 57.8/100 | ₹1457.10₹1457 | ₹39195.99₹39195.99 | 67.99Average 68.0 Average | 13.98%Average 13.98% Average | 19.33%Good 19.33% Good | 0.04Excellent 0.0 Excellent | 5.82%Good 5.82% Good | 15.64%Excellent 15.64% Excellent | 0.28% |
Garware Hi-Tech Films LimitedGarware Hi-Tech... GRWRHITECH • 500655 | 68.8/100 | ₹6891.50₹6892 | ₹16008.95₹16008.95 | 41.28Average 41.3 Average | 13.45%Average 13.45% Average | 17.63%Good 17.63% Good | 0.00Excellent 0.0 Excellent | 22.03%Excellent 22.03% Excellent | 16.47%Excellent 16.47% Excellent | 0.17% |
Shaily Engineering Plastics LimitedShaily Engineer... SHAILY • 501423 | 66.3/100 | ₹3375.20₹3375 | ₹15525.92₹15525.92 | 87.74Average 87.7 Average | 0.00%Poor 0.00% Poor | 34.04%Excellent 34.04% Excellent | 0.24Excellent 0.2 Excellent | 48.94%Excellent 48.94% Excellent | 20.63%Excellent 20.63% Excellent | 0.07% |
Finolex Industries LimitedFinolex Industr... FINPIPE • 500940 | 50.5/100 | ₹156.33₹156 | ₹9666.67₹9666.67 | 15.70Average 15.7 Average | 0.00%Poor 0.00% Poor | 12.17%Average 12.17% Average | 0.07Excellent 0.1 Excellent | -4.09%Poor -4.09% Poor | 3.50%Average 3.50% Average | 1.20% |
Time Technoplast LimitedTime Technoplas... TIMETECHNO • 532856 | 64/100 | ₹184.87₹185 | ₹9125.18₹9125.18 | 17.93Average 17.9 Average | 13.43%Average 13.43% Average | 18.24%Good 18.24% Good | 0.16Excellent 0.2 Excellent | 35.29%Excellent 35.29% Excellent | 15.23%Excellent 15.23% Excellent | 0.64% |
66.6/100 | ₹6225.50₹6226 | ₹8436.42₹8436.42 | 37.38Average 37.4 Average | 17.41%Good 17.41% Good | 23.61%Excellent 23.61% Excellent | 0.00Excellent 0.0 Excellent | 103.40%Excellent 103.40% Excellent | 26.05%Excellent 26.05% Excellent | 0.00% | |
Prince Pipes And Fittings LimitedPrince Pipes An... PRINCEPIPE • 542907 | 41.1/100 | ₹279.75₹280 | ₹3092.94₹3092.94 | 30.31Average 30.3 Average | 4.54%Poor 4.54% Poor | 6.26%Poor 6.26% Poor | 0.09Excellent 0.1 Excellent | -19.89%Poor -19.89% Poor | 4.64%Average 4.64% Average | 0.18% |
Apollo Pipes LimitedApollo Pipes Li... APOLLOPIPE • 531761 | 12.6/100 | ₹571.00₹571 | ₹2515.15₹2515.15 | — — | 0.00%Poor 0.00% Poor | 2.13%Poor 2.13% Poor | 0.15Excellent 0.2 Excellent | — — | 16.36%Excellent 16.36% Excellent | 0.14% |
Jai Corp LimitedJai Corp Limite... JAICORPLTD • 512237 | 53.3/100 | ₹96.92₹97 | ₹1700.95₹1700.95 | 18.18Average 18.2 Average | 11.69%Average 11.69% Average | 27.45%Excellent 27.45% Excellent | 0.00Excellent 0.0 Excellent | 12.82%Good 12.82% Good | 1.75%Average 1.75% Average | 0.46% |
Top Plastic Products - Industrial Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Supreme Industries Limited share price44594.55 Cr
- Astral Limited share price39195.99 Cr
- Garware Hi-Tech Films Limited share price16008.95 Cr
- Shaily Engineering Plastics Limited share price15525.92 Cr
- Finolex Industries Limited share price9666.67 Cr
Amerise Biosciences Ltd Quarterly Performance
Latest quarterly metrics for AMERISE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-57.89%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-45.45%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
15.54%
Compounded annual net profit growth over 5 years
Amerise Biosciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMERISE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amerise Biosciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Amerise Biosciences Ltd (AMERISE) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Amerise Biosciences Ltd
About AMERISE (Amerise Biosciences Ltd)
Amerise Biosciences Ltd is a fledgling enterprise venturing into the specialized field of industrial plastic products, currently laying the groundwork for future operations. While ...the company is in its nascent stages, the vision is to establish a robust manufacturing and distribution network catering to diverse industrial needs. Amerise aims to specialize in high-performance plastics, engineered for durability, resilience, and adaptability across various demanding applications. The core focus will be on creating custom solutions for sectors requiring superior materials, emphasizing innovation in plastic compound development and molding processes. Though currently focused on building infrastructure and developing key partnerships, Amerise Biosciences anticipates significant growth and impact as it moves towards full-scale production. The foundation of Amerise Biosciences' future success rests on a commitment to research and development, aimed at producing cutting-edge plastic products. The company intends to invest heavily in advanced technologies, including specialized extrusion and injection molding equipment, and a dedicated team of engineers and material scientists. This strategic focus will allow for the creation of specialized plastic components for a wide range of sectors, including automotive, aerospace, and construction. By incorporating sustainable practices into its manufacturing processes, Amerise Biosciences also aims to minimize its environmental impact, utilizing recycled materials and implementing energy-efficient technologies, furthering a commitment to responsible industry growth and resource management. Established with a refreshed purpose and vision, Amerise Biosciences Ltd leverages its corporate history as a launchpad for a new chapter in industrial plastics. Transitioning from previous ventures, the company has undergone a strategic re-alignment to concentrate on the burgeoning market for specialized plastic products. Headquartered in Ahmedabad, India, Amerise is strategically positioned to access a vibrant and diverse industrial ecosystem, offering substantial advantages in manufacturing and logistics. With a clear focus on establishing strong relationships with both suppliers and customers, Amerise Biosciences is dedicated to building a lasting legacy in the plastics industry through a commitment to quality, innovation, and customer satisfaction.
Company Details
Key Leadership
AMERISE Share Price: Frequently Asked Questions
What is the current share price of Amerise Biosciences Ltd?
Amerise Biosciences Ltd (AMERISE) trades at ₹0.85 on NSE and BSE. Market cap ₹6.28 (Cr). Educational data only.
What is the P/E ratio of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has a P/E of 313.91x vs industry average 20.83x.
What is the Bull Run score for Amerise Biosciences Ltd?
Amerise Biosciences Ltd has a Bull Run score of 8.8/100 based on 25+ financial parameters.
Does Amerise Biosciences Ltd pay dividends?
Amerise Biosciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has ROE of 0.37%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has debt-to-equity of 0.00.
Is Amerise Biosciences Ltd a good investment?
Bull Run gives Amerise Biosciences Ltd a score of 8.8/100. This is not investment advice — consult a SEBI-registered advisor.